Cited by 64Gastrointestinal motility and disordersPain Mechanisms and TreatmentsPsychosomatic Disorders and Their Treatments

The DOI matches its Crossref record; 268 of the 268 references it cites were found in a registry or an index.

Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity

Bueno, L., De Ponti, F., Fried, M., Kullak‐ublick, G. A., Kwiatek, M. A., Pohl, D., Quigley, E. M. M., Tack, J., Talley, N. J.·2007·Neurogastroenterology & Motility

DOI 10.1111/j.1365-2982.2006.00876.x

Open this paper in CoChat — free account

Abstract

Abstract Visceral hypersensitivity is considered a key mechanism in the pathogenesis of functional gastrointestinal (GI) disorders. Targeting visceral hypersensitivity seems an attractive approach to the development of drugs for functional GI disorders. This review summarizes current knowledge on targets for the treatment of visceral hypersensitivity, and the status of current and future drug and probiotic treatment development, and the role of pharmacogenomic factors.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2982.2006.00876.x

Cites

268 of 268 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–268 of 268

Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?
Quigley, E. M. M. (2005) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2005.00202.x · Cited by 65
Self-citation
Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome
Bazzocchi, G., Gionchetti, P., Almerigi, P. F., Amadini, C., & Campieri, M. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80164-5 · Cited by 64
Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea
Chey, W. D., & Cash, B. D. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.2.185 · Cited by 63
Activation of peripheral 5‐HT4receptors attenuates colonic sensitivity to intraluminal distension
Meerveld, B. G., Venkova, K. M., Hicks, G. A., Dennis, E., & Crowell, M. D. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00723.x · Cited by 59
Alosetron does not affect the visceral perception of gastric distension in healthy subjects
Zerbib, F., Varannes, S. B. D., Oriola, R. C., McDONALD, J., Isal, J. P., & GALMICHE, J. P. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00307.x · Cited by 59
Sensitization to Mechanical Stimulation by Inflammatory Mediators and by Mild Burn in Canine Visceral Nociceptors In Vitro
Koda, H., & Mizumura, K. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00593.2001 · Cited by 59
[Serotonin transporter gene polymorphism in healthy adults and patients with irritable bowel syndrome].
Lee, D. Y., Park, H., Kim, W. H., Lee, S. I., Seo, Y. J., & Choi, Y. (2004) · PubMed · Cited by 57
Indigestion and non-steroidal anti-inflammatory drugs
Seager, J. M., & Hawkey, C. J. (2001) · BMJ · doi:10.1136/bmj.323.7323.1236 · Cited by 55
Intestinal anti‐nociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action
Fioramonti, J., Gaultier, E., Toulouse, M., Sanger, G. J., & Bueno, L. P. (2003) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2003.00420.x · Cited by 53
Self-citation
Disturbances of Motility and Visceral Hypersensitivity in Irritable Bowel Syndrome: Biological Markers or Epiphenomenon
Quigley, E. M. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.02.010 · Cited by 52
Self-citation
Mode of inheritance in mood disorder families according to fluvoxamine response
Serretti, A., Franchini, L., Gasperini, M., Rampoldi, R., & Smeraldi, E. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10117.x · Cited by 52
Is there a SERT-ain association with IBS?
Camilleri, M. (2004) · Gut · doi:10.1136/gut.2004.039826 · Cited by 52
Modulation of gastric distension-induced sensations by small intestinal receptors
Feinle, C., Grundy, D., & Fried, M. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.1.g51 · Cited by 52
Self-citation
5‐HT 7 receptors mediate the inhibitory effect of 5‐HT on peristalsis in the isolated guinea‐pig ileum
Tuladhar, B. R., Ge, L., & Naylor, R. J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705184 · Cited by 50
Products of Cyclooxygenase-2 Catalysis Regulate Postoperative Bowel Motility
Josephs, M. D., Cheng, G., Ksontini, R., et al. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5692 · Cited by 49
Constitutive expression and function of cyclooxygenase-2 in murine gastric muscles
Porcher, C., Horowitz, B., Bayguinov, O. P., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.33065 · Cited by 49
Tegaserod
Scott, L. J., & Perry, C. M. (1999) · Drugs · doi:10.2165/00003495-199958030-00013 · Cited by 49
Functional Chest Pain
Mudipalli, R. S., Remes-Troche, J. M., Andersen, L., & Rao, S. S. C. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225521.36160.1b · Cited by 48
Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?
Holtmann, G., Gschossmann, J. M., Buenger, L., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36556 · Cited by 48
Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans1
Ladabaum, U., & Glidden, D. V. (2002) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2002.00344.x · Cited by 44
Prostaglandin EP receptor subtypes have distinctive effects on jejunal afferent sensitivity in the rat
Haupt, W., Jiang, W., Kreis, M. E., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20337 · Cited by 43
Probiotics in the Management of Irritable Bowel Syndrome: A Review of Clinical Trials
Hamilton-Miller, J. M. T. (2001) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v13i4.8025 · Cited by 43
Pharmacological characterization of the 5‐HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle
Janssen, P., Prins, N. H., Meulemans, A. L., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704716 · Cited by 42
The genetics of irritable bowel syndrome.
Saito, Y., Petersen, G., Locke, G., & Talley, N. J. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00184-9 · Cited by 42
Self-citation
Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation
Müller-Lissner, S. A., Holtmann, G., Rueegg, P. C., Weidinger, G., & Löffler, H. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02294.x · Cited by 41
Small intestinal motor abnormalities in patients with functional dyspepsia demonstrated by ambulatory manometry.
Jebbink, H. J. A., Henegouwen, G. P. V. B., Akkermans, L. M. A., & Smout, A. J. P. M. (1996) · Gut · doi:10.1136/gut.38.5.694 · Cited by 41
Antinociceptive properties of HTF 919 (tegaserod), a 5-HT4 receptor partial agonist, on colorectal distension in rats
Coelho, A.-M., Rovira, P., Fioramonti, J., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)85481-5 · Cited by 41
Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac
Goldstein, J. L., Eisen, G. M., Burke, T. A., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01219.x · Cited by 41
Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders – the clinical evidence
Kuiken, S. D., Tytgat, G. N. J., & Boeckxstaens, G. E. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02392.x · Cited by 40
Post-infectious irritable bowel syndrome
Spiller, R., & Campbell, E. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000194792.36466.5c · Cited by 39
A double blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectosigmoid distension in IBS patients
Lee, O., Munakata, J., Naliboff, B. D., Chang, L., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)85527-4 · Cited by 38
Probiotics in the Management of Irritable Bowel Syndrome: A Review of Clinical Trials
Hamilton-Miller, J. M. T. (2001) · Microbial Ecology in Health and Disease · doi:10.1080/089106001753341282 · Cited by 38
The influence of the novel 5‐HT 1A agonist R137696 on the proximal stomach function in healthy volunteers
Boeckxstaens, G. E., Tytgat, G. N. J., Wajs, E., et al. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00812.x · Cited by 37
Influence of 5‐HT3 receptor antagonists in visceromotor and nociceptive responses to rectal distension before and during experimental colitis in rats*
Morteau, O., Julia, V., Eeckhout, C., & Bueno, L. P. (1994) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1994.tb00837.x · Cited by 37
Self-citation
The role of tension receptors in colonic mechanosensitivity in humans
Corsetti, M., Gevers, A.-M., Caenepeel, P., & Tack, J. F. (2004) · Gut · doi:10.1136/gut.2004.038786 · Cited by 36
Self-citation
SEROTONIN and GASTROINTESTINAL FUNCTION
Gaginella, T. S., & Galligan, J. J. (2020) · CRC Press eBooks · doi:10.1201/9781003068983 · Cited by 35
CYP2C19 pharmacogenetics in the clinical use of proton‐pump inhibitors for gastro‐oesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms
Egan, L. J., Myhre, G. M., Mays, D. C., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01645.x · Cited by 34
The effects of tegaserod, a 5‐HT4 receptor agonist, on gastric emptying in a murine model of diabetes mellitus
Crowell, M. D., Mathis, C., Schettler, V. A., Yunus, T. S., & Lacy, B. E. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00681.x · Cited by 33
Meta‐analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase‐2‐specific inhibitor, compared with nonspecific nonsteroidal anti‐inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis
Eisen, G. M., Goldstein, J., Hanna, D. B., & Rublee, D. A. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02383.x · Cited by 32
Functional Chest Pain
Chahal, P. S., & Rao, S. S. C. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000156108.20871.bb · Cited by 31
Effect of cyclooxygenase‐2 inhibitors on gastric emptying and small intestinal transit in humans
Bouras, E. P., Burton, D. D., Camilleri, M., et al. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00547.x · Cited by 30
Cholecystokinin octapeptide increases rectal sensitivity to pain in healthy subjects
Sabaté, J., Gorbatchef, C., Flourié, B., et al. (2002) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2002.00370.x · Cited by 29
The Effects of Cisapride on Antroduodenal Co-ordination and Gastric Emptying
Johnson, A. G. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091229 · Cited by 29
Serotonin Transporter Gene Polymorphism in Healthy Adults and Patients with Irritable Bowel Syndrome
Xie, J., Li, Y., Nie, Y., Liang, P., & Zhang, L. (2005) · Academic Journal of Guangzhou Medical College · Cited by 29
Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord
Sun, Y.-N. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i12.1830 · Cited by 28
Lipid‐induced colonic hypersensitivity in irritable bowel syndrome: the role of 5‐HT3 receptors
Simrén, M., Simms, L., D'Souza, D. L., Abrahamsson, H., & Björnsson, E. S. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01399.x · Cited by 28
Effects of aspirin and prostaglandin E2 on interdigestive motility complex and duodenogastric reflux in man
Dooley, C. P., Mello, W. D., & Valenzuela, J. E. (1985) · Digestive Diseases and Sciences · doi:10.1007/bf01320256 · Cited by 27
Responses to cholecystokinin octapeptide in patients with functional abdominal pain syndromes
Roberts‐Thomson, I. C., Fettman, M. J., Jonsson, J. R., & Frewin, D. B. (1992) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1992.tb00983.x · Cited by 26
Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance
Bouin, M., Delvaux, M. M., Blanc, C., Lagier, E., Delisle, M., Fioramonti, J., Bueno, L. P., & Frexinos, J. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200105000-00018 · Cited by 24
Self-citation
Antinociceptive property of tegaserod in a rat model of chronic visceral hypersensitivity
Liang, L. X., ZHANG, Q., Qian, W., et al. (2005) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2005.00182.x · Cited by 24
Products of cyclooxygenase‐2 depress duodenal function in rats subjected to abdominal surgery
Pihl, L., & Nylander, O. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2006.01559.x · Cited by 21
Effects of Tropisetron, a 5-HT3 Receptor Antagonist, on Proximal Gastric Motor and Sensory Function in Nonulcer Dyspepsia
Klatt, S., Böck, W., Rentschler, J., et al. (1999) · Digestion · doi:10.1159/000007640 · Cited by 20
The Use of Probiotics in Functional Bowel Disease
Quigley, E. M. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.05.008 · Cited by 20
Self-citation
Oral S(+)-Ketamine Does Not Change Visceral Perception in Health
Kuiken, S. D., Berg, S. J. T. V. D., Tytgat, G. N. J., et al. (2004) · Digestive Diseases and Sciences · doi:10.1007/s10620-004-9563-6 · Cited by 19
Pharmacogenomics and Functional Gastrointestinal Disorders
Camilleri, M. (2005) · Pharmacogenomics · doi:10.2217/14622416.6.5.491 · Cited by 19
5-HT4 receptor antagonism potentiates inhibition of intestinal allodynia by 5-HT3 receptor antagonism in conscious rats
Smith, M. I., Banner, S. E., & Sanger, G. J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00513-3 · Cited by 18
Failure of oxethazaine to alter acid-induced esophageal pain
Hookman, P., Siegel, C. I., & Hendrix, T. R. (1966) · Digestive Diseases and Sciences · doi:10.1007/bf02233842 · Cited by 17
Gastrointestinal pharmacology: irritable bowel syndrome
Bueno, L. P. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.06.006 · Cited by 16
Self-citation
Constitutive cyclo‐oxygenase‐2 does not contribute to the development of human visceral pain hypersensitivity
Willert, R. P., Delaney, C. M., Hobson, A. R., et al. (2005) · European Journal of Pain · doi:10.1016/j.ejpain.2005.07.003 · Cited by 16
Tegaserod inhibits noxious rectal distention induced responses and limbic system c-Fos expression in rats with visceral hypersensitivity
Jiao, H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i19.2836 · Cited by 16
Talnetant GlaxoSmithKline.
Evangelista, S. (2005) · PubMed · Cited by 15
Double-Blind, Placebo-Controlled Study on Effects of Diclofenac Sodium and Indomethacin on Postprandial Gastric Motility in Man
Bassotti, G., Bucaneve, G., Furno, P., et al. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018883102636 · Cited by 14
5‐HT2B receptors do not modulate sensitivity to colonic distension in rats with acute colorectal hypersensitivity
Meerveld, B. G., Campbell-Dittmeyer, K. M., Johnson, A. C., et al. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00767.x · Cited by 13
G-protein mediated receptor-cell-coupling as a predictor for the long term response to treatment in patients with functional dyspepsia
Holtmann, G., Siffert, W., Grote, E., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)80396-7 · Cited by 11
Stretta procedure and esophageal sensitivity
Tack, J. F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.048 · Cited by 11
Self-citation
Effects of parenteral diclofenac sodium on upper gastrointestinal motility after food in man
Bassotti, G., Bucaneve, G., Betti, C., et al. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00626379 · Cited by 9
Non-steroidal anti-inflammatory drugs (NSAIDs) cause gastrointestinal intolerance and major bleeding--or do they?
Tenenbaum, J. (1987) · PubMed · Cited by 7
Tachykinin Receptor Antagonists: Silencing Neuropeptides with a Role in the Disturbed Gut
Holzer, P. D. (2004) · doi:10.1002/9780470760307.ch17 · Cited by 3

Flagged first, then by citations

Research works printed but not linked: 6

Tack J, 2004, A placebo‐controlled trial of the 5‐HT1A agonist R‐137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia, Gastroenterology, 126, A70
Tack J, 2002, A phase II placebo controlled randomized trial with tegaserod in functional dyspepsia patients with normal gastric emptying, Gastroenterology, 122, A154
Corsetti M, 2004, Influence of tegaserod on sensorimotor function of the descending colon in man, Gastroenterology, 126, A217
Willert RP, 2006, Human visceral pain hypersensitivity is not attenuated by a selective oral neurokinin‐1 (NK‐1) receptor antagonist. A randomized double blind placebo controlled pharmacodynamic study in healthy volunteers, Gastroenterology, 130, A26
Johanson ML, 2000, Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome, Am J Gastroenterol, 95, 1231, 10.1111/j.1572-0241.2000.02015.x · DOI · Paper page
Parker P, 2003, Synbiotic in irritable bowel syndrome: a double blind prospective randomised controlled trial, Gut, 52, A11

Sorted by citations

Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.027 · Cited by 2,012
The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials
Dimidi, E., Christodoulides, S., Fragkos, K. C., Scott, S. M., & Whelan, K. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.089151 · Cited by 316
Prebiotics and probiotics; modifying and mining the microbiota
Quigley, E. M. M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.004 · Cited by 238
Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: A randomized, double-blind, controlled study in chronic constipation
Magro, D. O., de Oliveira, L. M. R., Bernasconi, I., de Souza Ruela, M., Credidio, L., Barcelos, I. K., Leal, R. F., Ayrizono, M. D. L. S., Fagundes, J. J., Teixeira, L. D. B., et al. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-75 · Cited by 105
Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies
Quigley, E. M. M. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.009 · Cited by 67
Self-citation

See all 64

Authors: Bueno, L., De Ponti, F., Fried, M., Kullak‐ublick, G. A., Kwiatek, M. A., Pohl, D., Quigley, E. M. M., Tack, J., & Talley, N. J.
Affiliations: Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
University Hospital Zurich (CH)
University College Cork (IE)
KU Leuven (BE)
Mayo Clinic (US)
Corresponding author: Bueno, L.
ORCID: Pohl, D.
Quigley, E. M. M.
Tack, J.
Venue: Neurogastroenterology & Motility
Publisher: Wiley
Published: 2007-01
Volume: 19
Issue: s1
Pages: 89-119
ISSN: 1350-1925 (ISSN-L)
1365-2982
DOI: 10.1111/j.1365-2982.2006.00876.x
OpenAlex: W2032490947
Cited by: 64
References: 268
Citations by year: 2026: 1 · 2023: 2 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 2
FWCI: 1.41
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2 d)
Locations: Neurogastroenterology & Motility (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords: visceral hypersensitivity, functional gastrointestinal disorders, pharmacotherapy, probiotics, pharmacogenomics, drug development
MeSH terms: Animals, Gastrointestinal Diseases, Humans, Receptors, Serotonin, Serotonin, Serotonin Antagonists, Pain Threshold, Visceral Afferents, Serotonin Agents, Probiotics, Gastrointestinal Tract, Cyclooxygenase 2 Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks